e항원 음성 B형 간염 환자에서 높은 virus 수치의 위험성에 대한 연구 High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Gwang Hyeon Choi, Young-Suk Lim, et al. Alimentary pharmacology & therapeutics. 2019
간암의 넥사바 내성 기전 중 Raf-1 kinase inhibitory protein의 역할에 대한 연구 Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines. Jin Sun Kim, Gwang Hyeon Choi, Kang Mo Kim, et al. J Cancer Res Clin Oncol. 2018
재발성 혼합 간세포-담도암종에서 간동맥화학색전술 효과에 대한 연구 The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. Seong Kyun Na, Gwang Hyeon Choi, Han Chu Lee, et al. PLoS One. 2018
진행성 간암환자에서 넥사바 치료반응 예측 모델 개발에 대한 연구 Prognostic Scoring Models for Patients with Advanced Hepatocellular Carcinoma Undergoing Sorafenib in Real Life Practice. Gwang Hyeon Choi, Seungbong Han, Ju Hyun Shim, et al. American journal of clinical oncology 2017
진행성 간암에서 nexavar단독과 간동맥화학색전술 병용 치료를 비교한 연구 Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma. Gwang Hyeon Choi, Ju Hyun Shim, et al. Radiology 2013
A Case of Emphysematous Cholecystitis and Pneumobilia after Transarterial Chemoembolization for Hepatocellular Carcinoma. Gwang Hyeon Choi, Ju Hyun Shim, et al. The Korean Journal of Medicine. 2012
Long-term Clinical Outcomes in Patients with Autoimmune Hepatitis according to Treatment Response in Asian country. Jonggi Choi, Gwang Hyeon Choi, Kang Mo Kim, et al. Liver International 2019